117 related articles for article (PubMed ID: 8361218)
21. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
22. Total body irradiation dose and relapse risk after marrow transplantation for leukemia.
Frassoni F; Bacigalupo A; Marmont A; Scarpati D; Corvò R; Vitale V
Blood; 1991 Jun; 77(11):2543-4. PubMed ID: 2039837
[No Abstract] [Full Text] [Related]
23. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation for chronic myelogenous leukemia.
Champlin R
Curr Opin Oncol; 1990 Apr; 2(2):258-62. PubMed ID: 2095240
[No Abstract] [Full Text] [Related]
25. [National survey of total body irradiation for bone marrow transplantation with special reference to preparation regimen].
Inoue T; Mori T; Sugawara T; Iino Y; Masaoka T
Rinsho Hoshasen; 1990 Jan; 35(1):93-5. PubMed ID: 2179603
[TBL] [Abstract][Full Text] [Related]
26. 5q- in a case of chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
Soligo D; Romitti L; Bertolli V; Della Volpe A; Annaloro C; Lambertenghi Deliliers G
Haematologica; 1995; 80(5):437-9. PubMed ID: 8566886
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow transplantation for chronic myeloid leukaemia.
Goldman JM
Leukemia; 1992; 6 Suppl 2():22-3. PubMed ID: 1578936
[TBL] [Abstract][Full Text] [Related]
28. Busulfan/cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia.
Urban C; Schwinger W; Slavc I; Schmid C; Gamillscheg A; Lackner H; Hauer C; Pakisch B
Bone Marrow Transplant; 1990 May; 5(5):353-6. PubMed ID: 2190661
[TBL] [Abstract][Full Text] [Related]
29. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects.
Thall PF; Champlin RE; Andersson BS
Bone Marrow Transplant; 2004 Jun; 33(12):1191-9. PubMed ID: 15122310
[TBL] [Abstract][Full Text] [Related]
31. Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Koharazawa H; Kanamori H; Takabayashi M; Yamaji S; Taguchi J; Fujimaki K; Ishigatsubo Y
Bone Marrow Transplant; 2005 Jun; 35(12):1223-4. PubMed ID: 15880131
[No Abstract] [Full Text] [Related]
32. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.
Mackinnon S; Hows JM; Goldman JM; Arthur CK; Hughes T; Apperley JF; Jones L; Batchelor JR; Brookes P; Catovsky D
Exp Hematol; 1990 Jun; 18(5):421-5. PubMed ID: 2338131
[TBL] [Abstract][Full Text] [Related]
34. [Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].
Glejzer O; Sedzimirska M; Tomaszewska-Toporska B; Tomeczko J; Kołodziej J; Pacuszko T; Was A; Bocheńska J; Jaźwiec B; Klimczak A
Acta Haematol Pol; 1992; 23(2 Suppl 1):49-59. PubMed ID: 1488872
[TBL] [Abstract][Full Text] [Related]
35. [Successful second transplant from one-locus HLA-mismatched unrelated donor for graft rejection following initial transplant from another unrelated donor in a patient with chronic myelogenous leukemia].
Tanaka M; Kanamori H; Kuwabara H; Yamaji S; Kamijo A; Taguchi J; Fujita H; Fujisawa S; Matsuzaki M; Mohri H; Ishigatsubo Y
Rinsho Ketsueki; 2001 Aug; 42(8):656-8. PubMed ID: 11579507
[TBL] [Abstract][Full Text] [Related]
36. Reconstitution of T cell subset repertoire diversity following multiple antigen-mismatched bone marrow transplantation.
Friedman TM; Azhipa O; Zilberberg J; Tkachuk Y; Hsu JW; Rowley SD; Goldberg SL; Korngold R; Pecora AL; Preti RA
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1092-5. PubMed ID: 17084373
[No Abstract] [Full Text] [Related]
37. Successful allogeneic bone marrow transplantation in juvenile CML: conditioning or graft-versus-leukaemia effect?
Rassam SM; Katz F; Chessells JM; Morgan G
Bone Marrow Transplant; 1993 Mar; 11(3):247-50. PubMed ID: 8467291
[TBL] [Abstract][Full Text] [Related]
38. [Allogeneic bone marrow transplantation in the treatment of leukemia: analysis of 10 cases].
Cao LX; Zeng TQ; Chen H
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):415-7, 456. PubMed ID: 1684316
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
40. How do transplants cure chronic myelogenous leukemia?
Gale RP; Butturini A
Bone Marrow Transplant; 1992 Feb; 9(2):83-5. PubMed ID: 1571713
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
